Datasets:
Update README.md
Browse files
README.md
CHANGED
|
@@ -1,3 +1,118 @@
|
|
| 1 |
---
|
|
|
|
| 2 |
license: mit
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 3 |
---
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
---
|
| 2 |
+
language: en
|
| 3 |
license: mit
|
| 4 |
+
task_categories:
|
| 5 |
+
- tabular-classification
|
| 6 |
+
tags:
|
| 7 |
+
- long-covid
|
| 8 |
+
- multi-omics
|
| 9 |
+
- recovery
|
| 10 |
+
- systems-biology
|
| 11 |
+
- sios
|
| 12 |
+
- interaction-geometry
|
| 13 |
+
size_categories:
|
| 14 |
+
- n<1K
|
| 15 |
+
pretty_name: Long Covid Recovery Interaction Geometry
|
| 16 |
---
|
| 17 |
+
|
| 18 |
+
# What this dataset does
|
| 19 |
+
|
| 20 |
+
This dataset tests whether failed Long Covid recovery is better predicted by interaction geometry than by any single biological burden signal.
|
| 21 |
+
|
| 22 |
+
The target is not disease diagnosis.
|
| 23 |
+
|
| 24 |
+
The target is failed recovery.
|
| 25 |
+
|
| 26 |
+
# Core stability idea
|
| 27 |
+
|
| 28 |
+
A patient may show high biological burden and still recover if repair capacity remains strong and omics layers stay coherent.
|
| 29 |
+
|
| 30 |
+
A patient may show moderate burden and fail to recover if repair capacity weakens and biological layers begin to diverge.
|
| 31 |
+
|
| 32 |
+
The central hypothesis is:
|
| 33 |
+
|
| 34 |
+
```text
|
| 35 |
+
failed recovery = burden × disagreement × weak repair
|
| 36 |
+
|
| 37 |
+
Prediction target
|
| 38 |
+
label = 1
|
| 39 |
+
|
| 40 |
+
means failed or stuck recovery trajectory.
|
| 41 |
+
|
| 42 |
+
label = 0
|
| 43 |
+
|
| 44 |
+
means recovered or stable recovery trajectory.
|
| 45 |
+
|
| 46 |
+
Row structure
|
| 47 |
+
|
| 48 |
+
Each row represents a synthetic patient recovery state.
|
| 49 |
+
|
| 50 |
+
Columns:
|
| 51 |
+
|
| 52 |
+
scenario_id
|
| 53 |
+
ifn_signature
|
| 54 |
+
cytokine_activation
|
| 55 |
+
acute_phase_proteins
|
| 56 |
+
mitochondrial_stress
|
| 57 |
+
lipid_disruption
|
| 58 |
+
microbiome_instability
|
| 59 |
+
oxidative_stress
|
| 60 |
+
repair_response
|
| 61 |
+
symptom_score
|
| 62 |
+
label
|
| 63 |
+
Biological interpretation
|
| 64 |
+
|
| 65 |
+
The dataset is biology-shaped but synthetic.
|
| 66 |
+
|
| 67 |
+
It is designed to test whether models can detect interaction structure across immune, metabolic, microbiome, oxidative, and repair signals.
|
| 68 |
+
|
| 69 |
+
It does not claim patient-level validation.
|
| 70 |
+
|
| 71 |
+
Files
|
| 72 |
+
data/train.csv
|
| 73 |
+
data/test.csv
|
| 74 |
+
scorer.py
|
| 75 |
+
README.md
|
| 76 |
+
Evaluation
|
| 77 |
+
|
| 78 |
+
Submit predictions as:
|
| 79 |
+
|
| 80 |
+
scenario_id,prediction
|
| 81 |
+
LC101,0
|
| 82 |
+
LC102,0
|
| 83 |
+
LC103,1
|
| 84 |
+
|
| 85 |
+
Run:
|
| 86 |
+
|
| 87 |
+
python scorer.py predictions.csv data/test.csv
|
| 88 |
+
|
| 89 |
+
The scorer reports:
|
| 90 |
+
|
| 91 |
+
accuracy
|
| 92 |
+
precision
|
| 93 |
+
recall
|
| 94 |
+
f1
|
| 95 |
+
confusion matrix
|
| 96 |
+
Structural Note
|
| 97 |
+
|
| 98 |
+
This dataset is part of the Clarus / SIOS synthetic benchmark series.
|
| 99 |
+
|
| 100 |
+
It is designed to test whether models can identify latent stability geometry rather than rely on single-variable correlation.
|
| 101 |
+
|
| 102 |
+
The hidden structure is not intended to represent a clinical rule.
|
| 103 |
+
|
| 104 |
+
The purpose is to evaluate whether a model can reason across interacting biological signals.
|
| 105 |
+
|
| 106 |
+
Production Deployment
|
| 107 |
+
|
| 108 |
+
This dataset should not be used for clinical decision-making.
|
| 109 |
+
|
| 110 |
+
A production version would require validated patient-level Long Covid multi-omics data, longitudinal outcomes, and independent external testing.
|
| 111 |
+
|
| 112 |
+
Enterprise & Research Collaboration
|
| 113 |
+
|
| 114 |
+
This benchmark can be extended into real-data research using public or partner datasets containing transcriptomics, proteomics, metabolomics, immune profiling, symptom trajectories, and recovery outcomes.
|
| 115 |
+
|
| 116 |
+
License
|
| 117 |
+
|
| 118 |
+
MIT
|